SCM
IMNM icon

Sio Capital Management’s Immunome IMNM Stock Holding History

Sio Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63M Sell
124,168
-40,942
-25% -$876K 0.44% 43
2026
Q1 		$3.61M Buy
+165,110
New +$3.67M 0.52% 45

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Sio Capital Management's IMNM Position: Q2 2026 in Review

Sio Capital Management reduced its Immunome (IMNM) stake by 25% in Q2 2026, selling an estimated $876K and leaving 124,168 shares worth $2.63M. The position accounts for 0.44% of the portfolio, ranked #43.

Sio Capital Management first reported a position in IMNM in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.61M in Q1 2026. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Sio Capital Management held 124,168 shares of Immunome worth $2.63M as of Q2 2026.
  • Sio Capital Management sold 40,942 Immunome shares in Q2 2026, an estimated $876K.
  • Immunome made up 0.44% of Sio Capital Management's portfolio in Q2 2026, its #43 holding.
  • Sio Capital Management first reported a position in Immunome in Q1 2026 and has held it in 2 quarters since.
  • Sio Capital Management's Immunome position peaked at $3.61M in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.